Isolation of in Oral Candidiasis: First Report Among Cancer Patients in Iran
Overview
Authors
Affiliations
Background And Purpose: Oropharyngeal candidiasis (OPC) is a fungal infection of the oral cavity caused by the members of complex. Although , as a part of the complex, is considered to be mostly responsible for the development of vulvovaginal candidiasis, it may be associated with a wider clinical spectrum.
Case Report: This report described two cases diagnosed with oral candidiasis during the receipt of treatment for malignancies. Conventional and molecular tests were performed on the samples collected from the patients' oral cavities. The test results revealed as the causative agent of oral candidiasis. Furthermore, in vitro antifungal susceptibility test indicated the full susceptibility of all isolates to caspofungin. However, the data were also suggestive of the resistance against fluconazole and amphotericin B. Caspofungin was used as the main antifungal agent for the treatment of oral candidiasis, resulting in the improvement of thrush in patients. The resistance of to fluconazole and amphotericin B suggests the necessity of performing in vitro susceptibility testing on the isolates for the selection of appropriate antifungal agents.
Conclusion: As the findings indicated, the achievement of knowledge regarding as an emerging non-albicans Candida species and its antifungal susceptibility profile is crucial to select antifungal prophylaxis and empirical therapy for oral candidiasis in cancer patients undergoing chemotherapy.
None: non.
Jonani B, Kasule E, Bwire H, Mboowa G Diagn Progn Res. 2024; 8(1):16.
PMID: 39639364 PMC: 11619109. DOI: 10.1186/s41512-024-00180-6.
Emerging Antifungal Resistance in Fungal Pathogens.
Hui S, Gifford H, Rhodes J Curr Clin Microbiol Rep. 2024; 11(2):43-50.
PMID: 38725545 PMC: 11076205. DOI: 10.1007/s40588-024-00219-8.
Sadeghi A, Houri H, Lotfali E, Ghadirzadeh E, Rajabnia M Med Mycol Case Rep. 2024; 43:100625.
PMID: 38283389 PMC: 10820661. DOI: 10.1016/j.mmcr.2023.100625.
Oral colonization and anti-fungal susceptibility pattern in patients with hematological malignancy.
Talebshoushtari Zadeh M, Lotfali E, Fattahi M, Abolgasemi S Curr Med Mycol. 2023; 8(3):18-22.
PMID: 37051553 PMC: 10084485. DOI: 10.18502/cmm.8.3.11210.
de Melo Pereira G, Leal Maske B, de Carvalho Neto D, Karp S, De Dea Lindner J, Martin J Microorganisms. 2022; 10(9).
PMID: 36144457 PMC: 9502980. DOI: 10.3390/microorganisms10091855.